A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder - Rosler, M; Fischer, R; Ammer, R (Eur Arch Psychiatry Clin Neurosci, 2009)